| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74e6f28977b1a8bbe18d4e8a9c81f760
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3c140f3a015bdbd96b4eb3537370fd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60b9c9f6cd422dc95bbe5741ce21acd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f874eb11d4775decc4fd06a6071a4c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6c64bf2491f06ecc512bb7eded4fe0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adcf3d71b379f44b8e487f3f3e660581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00ff81127e0eb99519190171b957e4fa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-162 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2008-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f76ca3656f10f0248238ae48118f63ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83275dd48a6995cdeb973089d8b9bc0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12d65039739436d3ed064cce7c9acee5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1579339e28ef05f8725a28b6764c5cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5f60f577f674469d82daf6b1063d29d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b53da44a6d39f859f7edd759bbbbe76 |
| publicationDate |
2009-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009013352-A1 |
| titleOfInvention |
Native gp41 assay |
| abstract |
The present invention concerns a method for identifying compounds that decrease the ability of Human Immunodeficiency Virus (HIV) to enter previously uninfected cells. More specifically it relates to a homogeneous competitive cell-based binding assay for the identification of HIV-1 entry fusion inhibitors on a high content screening platform or flow cytometric-based read out. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012092971-A1 |
| priorityDate |
2007-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |